This NDC is on FDA's drug shortage list (posted Nov 3, 2023)
Product Information
CROMOLYN 100 MG/5 ML ORAL CONC is a generic product labeled by Micro Labs Limited, priced at $0.3490 per ML under NDC 42571013252. Its NADAC has been published 444 times since Jul 26, 2017.
FDA first approved this application on Apr 4, 2013. Its Orange Book therapeutic-equivalence code is AA.
Strength
100 mg/5mL
Manufacturer
Micro Labs LimitedNDC
42571013252
Classification
Generic
Dosage Form
SOLUTION, CONCENTRATE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CROMOLYN SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA202745FDA Approved
4/4/2013
TE Code
AA
On Market Since
5/4/2013
Pharmacological Classes
Price Statistics
The NADAC for CROMOLYN 100 MG/5 ML ORAL CONC has been published 444 times since Jul 26, 2017, and over the history we have for it it has declined 55.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3490 per ML |
|---|---|
| All-time high | $0.8713 (Jan 10, 2018) |
| All-time low | $0.1665 (Nov 20, 2024) |
| 52-week high | $0.3490 |
| 52-week low | $0.3141 |
| Median price | $0.3906 |
| Average price | $0.4309 |
| Largest weekly change | +85.7% (Jan 17, 2024) |
| Weeks tracked | 444 |
| Tracking since | Jul 26, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Cromolyn sodium market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Micro Labs Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Cromolyn sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Mast Cell Stabilizer class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CROMOLYN 100 MG/5 ML ORAL CONC?
The current National Average Drug Acquisition Cost (NADAC) for CROMOLYN 100 MG/5 ML ORAL CONC, manufactured by Micro Labs Limited, is $0.3490 per ML (NDC 42571013252), effective Sep 30, 2026.
How has the price of CROMOLYN 100 MG/5 ML ORAL CONC changed over time?
Over the history we have for it, the NADAC for CROMOLYN 100 MG/5 ML ORAL CONC has declined 55.4%. It has been tracked across 444 weekly CMS publications since Jul 26, 2017.
What are the highest and lowest recorded NADAC prices for CROMOLYN 100 MG/5 ML ORAL CONC?
Since Jul 26, 2017, the NADAC for CROMOLYN 100 MG/5 ML ORAL CONC has ranged from a low of $0.1665 (Nov 20, 2024) to a high of $0.8713 (Jan 10, 2018), with a median of $0.3906 per ML.
Are there cheaper alternatives to CROMOLYN 100 MG/5 ML ORAL CONC?
No other NADAC-published product currently shares the active ingredient and strength of CROMOLYN 100 MG/5 ML ORAL CONC in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CROMOLYN 100 MG/5 ML ORAL CONC?
CROMOLYN 100 MG/5 ML ORAL CONC (NDC 42571013252) is labeled by Micro Labs Limited, and CMS classifies it as a generic product.
Is CROMOLYN 100 MG/5 ML ORAL CONC in shortage?
Yes — NDC 42571013252 is currently listed in FDA's drug shortage database (posted Nov 3, 2023).